Literature DB >> 10620556

Familial microscopic hematuria caused by hypercalciuria and hyperuricosuria.

M Praga1, R Alegre, E Hernández, E Morales, B Domínguez-Gil, A Carreño, A Andrés.   

Abstract

We report 12 patients belonging to five different families in whom persistent isolated microhematuria was associated with hypercalciuria and/or hyperuricosuria. Four patients had episodes of gross hematuria, three patients had passed renal stones, and a history of nephrolithiasis was obtained in four of the families (80%). Calcium oxalate and uric acid crystals were commonly observed in the urine sediments. Urinary erythrocytes had a normal appearance on phase-microscopic examination. Reduction of calciuria and uricosuria by thiazide diuretics, allopurinol, forced fluid intake, and dietetic measures led to a persistent normalization of urine sediment with complete disappearance of hematuria. Determination of calcium and uric acid urinary excretions should be included in the study of familial hematuria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620556     DOI: 10.1016/S0272-6386(00)70313-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Metabolic risk factors in children with asymptomatic hematuria.

Authors:  Francisco Rodolfo Spivacow; Elisa Elena Del Valle; Paula Gabriela Rey
Journal:  Pediatr Nephrol       Date:  2016-02-25       Impact factor: 3.714

2.  The metabolic etiology of urolithiasis in Turkish children.

Authors:  Mustafa Bak; Rana Ural; Hasan Agin; Erkin Serdaroglu; Sebnem Calkavur
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

3.  High dose vitamin D3 attenuates the hypocalciuric effect of thiazide in hypercalciuric rats.

Authors:  Hye Ryoun Jang; Jay Wook Lee; Sejoong Kim; Nam Ju Heo; Jeong Hwan Lee; Hyo Sang Kim; Ji Yong Jung; Yun Kyu Oh; Ki Young Na; Jin Suk Han; Kwon Wook Joo
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.